Literature DB >> 7498984

Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).

I F Benter1, D I Diz, C M Ferrario.   

Abstract

We have suggested that angiotensin-(1-7) [Ang-(1-7)] may oppose the pressor activity of angiotensin II (Ang II). This hypothesis was supported by the fact that long-term intravenous infusion of Ang-(1-7) transiently lowers blood pressure in spontaneously hypertensive rats (SHR). We now investigated whether the pressor sensitivity to bolus injections of either phenylephrine (PE) or Ang II was altered on day 12 of an Ang-(1-7) infusion when blood pressure in the SHR had returned to hypertensive levels. SHR (n = 10) and WKY rats (n = 8) were given Ang-(1-7) intravenously via osmotic minipumps at a dose of 24 micrograms/kg per hour for 2 weeks. On day 12 of the infusion, mean arterial pressure and heart rate in halothane-anesthetized rats were similar in Ang-(1-7)-treated SHR (142 +/- 6 mm Hg; 388 +/- 9 beats per minute) and those infused with vehicle (146 +/- 5 mm Hg; 392 +/- 13 beats per minute). Pressor responsiveness to PE in Ang-(1-7)-treated SHR was 22% less at a dose of 10 micrograms, while pressor responses to Ang II decreased by 20% and 25% at doses of 0.05 and 0.1 micrograms, respectively, compared with the vehicle-treated SHR (P < .05). There were no effects of the Ang-(1-7) infusion on pressor responses to Ang II or PE in WKY rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498984     DOI: 10.1161/01.hyp.26.6.1138

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.

Authors:  Katsunori Isa; Amy C Arnold; Brian M Westwood; Mark C Chappell; Debra I Diz
Journal:  Hypertens Res       Date:  2011-09-22       Impact factor: 3.872

2.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

3.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

4.  Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function.

Authors:  Debra I Diz; Jasmina Varagic; Leanne Groban
Journal:  Future Cardiol       Date:  2008-05

5.  Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.

Authors:  N M Mordwinkin; C J Meeks; S S Jadhav; T Espinoza; N Roda; G S diZerega; S G Louie; K E Rodgers
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

Review 6.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

7.  Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons.

Authors:  Amit Modgil; Qi Zhang; Ajeeth Pingili; Neha Singh; Fanrong Yao; Jingyan Ge; Lirong Guo; Chengluan Xuan; Stephen T O'Rourke; Chengwen Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

8.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

9.  Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.

Authors:  Debra I Diz; Maria Antonia Garcia-Espinosa; Patricia E Gallagher; Detlev Ganten; Carlos M Ferrario; David B Averill
Journal:  J Cardiovasc Pharmacol       Date:  2008-06       Impact factor: 3.105

Review 10.  New angiotensins.

Authors:  Jasmina Varagic; Aaron J Trask; Jewell A Jessup; Mark C Chappell; Carlos M Ferrario
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.